These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12036933

  • 1. In vivo antitumor effect of CD40L-transduced tumor cells as a vaccine for B-cell lymphoma.
    Briones J, Timmerman J, Levy R.
    Cancer Res; 2002 Jun 01; 62(11):3195-9. PubMed ID: 12036933
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA, Bowers WJ, Muller J, Housekneckt V, Giuliano RE, Federoff HJ, Rosenblatt JD.
    Cancer Res; 2002 Nov 15; 62(22):6545-51. PubMed ID: 12438249
    [Abstract] [Full Text] [Related]

  • 6. Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma.
    Liu Y, Xia D, Li F, Zheng C, Xiang J.
    Cancer Gene Ther; 2005 Feb 15; 12(2):122-32. PubMed ID: 15565183
    [Abstract] [Full Text] [Related]

  • 7. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
    Takahashi S, Yotnda P, Rousseau RF, Mei Z, Smith S, Rill D, Younes A, Brenner MK.
    Cancer Gene Ther; 2001 May 15; 8(5):378-87. PubMed ID: 11477458
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine.
    Guinn BA, DeBenedette MA, Watts TH, Berinstein NL.
    J Immunol; 1999 Apr 15; 162(8):5003-10. PubMed ID: 10202049
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Therapeutic vaccination against murine lymphoma by intratumoral injection of recombinant fowlpox virus encoding CD40 ligand.
    Liu A, Guardino A, Chinsangaram L, Goldstein MJ, Panicali D, Levy R.
    Cancer Res; 2007 Jul 15; 67(14):7037-44. PubMed ID: 17638917
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
    Yurkovetsky ZR, Shurin GV, Barry DA, Schuh AC, Shurin MR, Robbins PD.
    J Gene Med; 2006 Feb 15; 8(2):129-37. PubMed ID: 16288496
    [Abstract] [Full Text] [Related]

  • 16. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P, Gravisaco MJ, Barcala V, Escalada A, Di Sciullo P, Waldner C, Mongini C.
    Vaccine; 2008 Jan 30; 26(5):697-705. PubMed ID: 18155328
    [Abstract] [Full Text] [Related]

  • 17. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ.
    Clin Cancer Res; 2002 Nov 30; 8(11):3561-9. PubMed ID: 12429647
    [Abstract] [Full Text] [Related]

  • 18. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X, Wang Y, Dietrich MF, Andreeff M, Arlinghaus RB.
    Oncogene; 2006 Jul 27; 25(32):4483-90. PubMed ID: 16547503
    [Abstract] [Full Text] [Related]

  • 19. CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
    Sandler AD, Chihara H, Kobayashi G, Zhu X, Miller MA, Scott DL, Krieg AM.
    Cancer Res; 2003 Jan 15; 63(2):394-9. PubMed ID: 12543793
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.